Dipna Pharmachem Reports Q1 FY27 Standalone Financial Results
Dipna Pharmachem Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 11:21 pm
Dipna Pharmachem Reports Q1 FY27 Standalone Financial Results Dipna Pharmachem reported standalone total income of Rs 2,379.06 lakhs for the quarter ended 30th Jun'26, rising 28.60% YoY from Rs 1,850.04 lakhs in 30th Jun'25 and up sharply QoQ from Rs 205.03 lakhs. Net profit declined 30.87% YoY to Rs 39.42 lakhs compared to Rs 57.02 lakhs in 30th Jun'25, but grew 120.72% QoQ from Rs 17.86 lakhs. Basic and diluted EPS stood at Rs 0.15 versus Rs 0.24 YoY. Total expenses reached Rs 2,326.64 lakhs, primarily driven by purchase of stock-in-trade at Rs 1,890.28 lakhs.
Original exchange filing (PDF)
More announcements from Dipna Pharmachem Ltd
- Outcome of Board Meeting held today i.e. 4th November, 2026 路 04 Nov 2026
- Outcome of Board Meeting held today i.e. 4th November, 2026 路 04 Nov 2026
- Reconstitution of the Committee 路 04 Nov 2026
- Outcome and Intimation Under Regulation 30 of SEBI (LODR) Regulations, 2015 路 04 Nov 2026
- Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 04 Nov 2026
- Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) .... 路 01 Nov 2026
- Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 24 Oct 2026
- Announcement under Regulation 30 (LODR) - Resignation of Director 路 24 Oct 2026
